After the initial public offering (IPO) market took a pause at the end of the summer, nine traditional IPOs are slated to raise over $3.8 billion in the week ahead.
Turing Holding Corp. (TWKS ), better known as Thoughtworks, plans to raise more than $847 million from over 36.8 million shares priced between $18 to $20 each. The tech consultancy provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers.
On Holding AG (ONON ) plans to raise $715.3 million from 31.1 million shares priced in the range of $18 to $20 each. The Swiss shoe brand is a global provider of premium athletic footwear, apparel, and accessories using sustainable materials and its proprietary technology.
Sportradar Group AG (SRAD ) plans to raise $611.8 million from 19 million shares priced between $25 to $28 each. The Swiss company provides software, data, and content to sports leagues, betting operators, and media companies, covering over 750,000 events annually. The company had recently ended talks to go public via SPAC, choosing instead to debut through IPO.
Dutch Bros Inc. (BROS ) plans to raise more than $484 million from over 21 million shares priced in the range of $18 to $20 each. The Oregon-based drive-thru coffee chain operated 471 locations in the United States.
Definitive Healthcare Corp. (DH ) plans to raise more than $429 million from about 15.5 million shares priced between $21 to $24 each. The company provides a healthcare commercial intelligence and analytics platform, which enables users to analyze, navigate, and sell into the healthcare industry.
ForgeRock, Inc. (FORG ) plans to raise $303.6 million from 11 million shares priced between $21 to $24 each. The company provides identity and access management software, offering a platform to provision, authenticate, and govern all types of digital identities.
DICE Molecules Holdings, LLC (DICE ) plans to raise $195.5 million from 10 million shares priced between $15 to $17 each. The immunology-focused biotech is developing oral small molecule therapies to treat chronic diseases. The company plans to initiate a Phase 1 clinical trial of its lead candidate, but do not offer a timeline.
PROCEPT BioRobotics Corp. (PRCT ) plans to raise $151.8 million from 5.5 million shares priced between $22 to $24 each. The surgical robotics company develops surgical robotics systems for minimally-invasive urologic surgery with focus on treating benign prostatic hyperplasia.
Tyra Biosciences, Inc. (TYRA ) plans to raise over $123 million from 6.7 million shares priced between $14 to $16 each. The oncology-focused biotech is developing FGFR kinase inhibitors for cancer, with focus on solid tumors. The company's lead candidate is initially focus on bladder cancer, with Tyra expecting to submit an Investigative New Drug form to the Food and Drug Administration for it in mid-2022.
